The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC
Clinical trial NCT05213884 · COMPLETED
Trial details
- NCT number
- NCT05213884
- Sponsor
- Chongqing University Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2026-02-08
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.